Here, we first analyzed FOXO3 expression in HCC samples and its involvement in patient survival, observing that FOXO3 levels in HCC tissues are significantly higher than those of healthy liver samples and finding that enhanced FOXO3 expression correlates with poor patient prognosis. The gene discussed is FOXO3; the disease is hepatocellular carcinoma.